Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
135,488,140
-
Total 13F shares
-
105,716,035
-
Share change
-
+2,396,724
-
Total reported value
-
$1,671,181,802
-
Put/Call ratio
-
128%
-
Price per share
-
$15.80
-
Number of holders
-
279
-
Value change
-
+$44,748,502
-
Number of buys
-
153
-
Number of sells
-
117
Institutional Holders of ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) as of Q2 2025
As of 30 Jun 2025,
ARROWHEAD PHARMACEUTICALS, INC. - Common Stock (ARWR) was held by
279 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
105,716,035 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, Avoro Capital Advisors LLC, STATE STREET CORP, Slate Path Capital LP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC, Siren, L.L.C., and MARSHALL WACE, LLP.
This page lists
279
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.